Fibrillary glomerulonephritis: clinicopathological characteristics and treatment in a spanish tertiary center
In our study, FGN showed poor prognosis and partial response to rituximab. FGN with hypoalbuminemia had worse outcomes. Prospective studies and larger cohorts are needed to validate these findings and optimize its management.
Authors
- Irene Latorre Agraz
- Oriol Bestard (ORCID: https://orcid.org/0000-0001-9468-7920)
- Sheila Rubio Bermejo
- Sara Núñez-Delgado (ORCID: https://orcid.org/0000-0002-3481-2520)
- Natàlia Ramos Terrades (ORCID: https://orcid.org/0000-0001-9832-326X)
- Juan León-Román
- María José Soler
- Efraín Tatis
- María Alejandra Gabaldón
- Néstor Toapanta
- Marina López-Martinez
Institutions
- Vall d'Hebron Hospital Universitari (ES)
Publication Details
- Journal
- Nefrología (English Edition)
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.nefroe.2026.501417
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00